We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance on security measures for transporting controlled drugs in the UK or internationally.
Guidance for local authorities, public health bodies and the NHS on using ‘deep dive’ self-assessment tools to improve their tobacco control work.
Plain English and Easy-read guides providing information on influenza (flu) and vaccination.
Guidance on reducing the risk of getting MERS-CoV for UK residents and travellers to the Middle East.
This protocol is for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza vaccination programme.
A reference guide for sample takers in the NHS Cervical Screening Programme
Information for parents of babies who carry the sickle cell gene.
There are currently 2 recognised viruses that cause haemorrhagic fever illnesses in Bolivia that are classed as high consequence infectious diseases (HCIDs). These are Machupo virus (MACV) and Chapare virus (CHAPV).
This guidance has been produced in collaboration with the Department for Education (DfE) for those who work in, or manage, schools or early years settings.
Information on C. auris, how it can spread, how patients are tested and treated, and what people who are carrying it can do to help prevent spreading it.
Patient group direction (PGD) template to support the provision of hepatitis A and B (HepA/B) vaccine to individuals requiring protection against hepatitis A and hepatitis B.
Guidance for healthcare practitioners on the hexavalent vaccine programme, including its use in the selective neonatal hepatitis B programme.
Information for health professionals about how, and in what circumstances, women can opt out temporarily or permanently from breast screening.
Information for healthcare practitioners on the changes to the infant pneumococcal vaccination schedule.
This chart shows the regulation of precursor chemicals in the UK.
Information about newborn screening tests for parents of babies in special care units.
Advice for women who are pregnant or considering pregnancy, who are pregnant and diagnosed with Zika, and for women whose baby is possibly affected.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).